Drug company shares are down amid President Donald Trump’s assault on the industry, but some in Congress see value.

As North America CEO, Richard will advance Sun Pharma's diverse portfolio of innovative medicines, generics and over-the-counter products in both the U.S. and Canada. With a background spanning ...

The study demonstrates promising results of prolonged release and a favorable safety profile of CBD following a single subcutaneous administration of LPT-CBD in minipigs.

Design consultancy Elmwood set out to preserve the nostalgic familiarity of Ribena when revamping the logo of the British squash brand while dialling up its most recognisable qualities.

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...

In Germany's pharmaceutical industry, advanced testing methods like TGA and DSC are crucial for maintaining high standards of product quality and stability.

Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment o ...

The impact of pharmaceutical roundtripping on the trade balance is both too big to continue and too big to ignore. Time for some real changes.

India's Glenmark Pharmaceuticals said on Thursday its innovation arm, Ichnos Glenmark Innovation (IGI), and AbbVie have signed an exclusive global licensing agreement for IGI's cancer treatment, ISB ...

Recombinant Factor C endotoxin detection technology is crucial in pharmaceutical manufacturing for enhancing product safety and supporting sustainability goals.

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) is among the best growth stocks to invest in for the next 5 years. Gautam Patel, the director of Amneal Pharmaceuticals, Inc.

Lyon, France-based late-stage clinical biotech MaaT Pharma has presented new preclinical data for MaaT034 at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago.